Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
Texas file SB2308, before the Texas Legislature. Passed as of 2025-06-11.
Latest action: Effective immediately
Read the official record for SB2308
See everything up for a vote · This week in Texas · See what we have filed with the clerk